Efectividad antihipertensiva y tolerabilidad de lercanidipino en diabéticos, en pacientes con hipertensión sistólica aislada y en ancianos. Análisis de subgrupos del estudio ELYPSE
Antihipertensive effectiveness and tolerability of lercanipidine in diabetics, isolated systolic hypertension patients and old men. ELYPSE study subgroup analysis
V. Barrios Alonsoa,
, J.P. Tomás Zarlengaa, A. Navarro Limab, A. Esteras Sierrac, M. Luque Oterod, J. Romero Juliac, J. Tamargo Menéndeze, L. Prieto Valientee, I. Herranz Tejedore, J. Navarro Cide, L.M. Ruilope Uriostef, en nombre de los investigadores del estudio ELYPSE
Autor para correspondencia
vbarriosa@meditex.es
vbarrios.hrc@salud.madrid.org
Correspondencia: Instituto de Cardiología. Hospital Ramón y Cajal. Ctra. de Colmenar km 9.100. 28034 Madrid.
vbarrios.hrc@salud.madrid.org
Correspondencia: Instituto de Cardiología. Hospital Ramón y Cajal. Ctra. de Colmenar km 9.100. 28034 Madrid.
Leído
2395
Vecesse ha leído el artículo
517
Total PDF
1878
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 2 | 2 |
| 2025 11 | 0 | 8 | 8 |
| 2025 10 | 0 | 5 | 5 |
| 2025 9 | 0 | 4 | 4 |
| 2025 8 | 0 | 2 | 2 |
| 2025 7 | 0 | 3 | 3 |
| 2025 6 | 0 | 3 | 3 |
| 2025 5 | 0 | 1 | 1 |
| 2025 4 | 0 | 2 | 2 |
| 2025 3 | 0 | 6 | 6 |
| 2025 2 | 0 | 5 | 5 |
| 2025 1 | 0 | 3 | 3 |
| 2024 11 | 0 | 2 | 2 |
| 2024 10 | 0 | 2 | 2 |
| 2024 9 | 0 | 5 | 5 |
| 2024 8 | 0 | 2 | 2 |
| 2024 6 | 0 | 3 | 3 |
| 2024 5 | 0 | 5 | 5 |
| 2024 4 | 0 | 3 | 3 |
| 2024 3 | 0 | 15 | 15 |
| 2024 2 | 0 | 6 | 6 |
| 2024 1 | 0 | 10 | 10 |
| 2023 12 | 0 | 1 | 1 |
| 2023 10 | 0 | 3 | 3 |
| 2023 9 | 0 | 1 | 1 |
| 2023 7 | 0 | 4 | 4 |
| 2023 6 | 0 | 8 | 8 |
| 2023 5 | 0 | 7 | 7 |
| 2023 4 | 0 | 14 | 14 |
| 2023 3 | 2 | 3 | 5 |
| 2023 2 | 0 | 11 | 11 |
| 2022 11 | 0 | 10 | 10 |
| 2022 10 | 0 | 2 | 2 |
| 2022 9 | 0 | 9 | 9 |
| 2022 8 | 0 | 3 | 3 |
| 2022 7 | 0 | 2 | 2 |
| 2022 6 | 0 | 4 | 4 |
| 2022 3 | 0 | 1 | 1 |
| 2021 12 | 0 | 5 | 5 |
| 2021 10 | 0 | 1 | 1 |
| 2021 6 | 0 | 1 | 1 |
| 2021 5 | 0 | 1 | 1 |
| 2020 1 | 0 | 2 | 2 |
| 2020 12 | 0 | 2 | 2 |
| 2020 9 | 0 | 2 | 2 |
| 2020 6 | 0 | 1 | 1 |
| 2020 5 | 0 | 3 | 3 |
| 2020 4 | 0 | 2 | 2 |
| 2020 3 | 0 | 3 | 3 |
| 2020 1 | 0 | 1 | 1 |
| 2019 12 | 0 | 2 | 2 |
| 2019 11 | 0 | 5 | 5 |
| 2019 10 | 0 | 7 | 7 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 2 | 2 |
| 2019 6 | 0 | 2 | 2 |
| 2019 5 | 0 | 18 | 18 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 2 | 2 | 4 |
| 2018 3 | 3 | 5 | 8 |
| 2018 2 | 3 | 2 | 5 |
| 2018 1 | 3 | 1 | 4 |
| 2017 12 | 6 | 2 | 8 |
| 2017 11 | 5 | 5 | 10 |
| 2017 10 | 12 | 3 | 15 |
| 2017 9 | 5 | 4 | 9 |
| 2017 8 | 7 | 3 | 10 |
| 2017 7 | 10 | 2 | 12 |
| 2017 6 | 6 | 21 | 27 |
| 2017 5 | 11 | 9 | 20 |
| 2017 4 | 10 | 2 | 12 |
| 2017 3 | 11 | 19 | 30 |
| 2017 2 | 15 | 3 | 18 |
| 2016 1 | 16 | 2 | 18 |
| 2016 12 | 40 | 3 | 43 |
| 2016 11 | 30 | 7 | 37 |
| 2016 10 | 33 | 6 | 39 |
| 2016 9 | 20 | 7 | 27 |
| 2016 8 | 8 | 4 | 12 |
| 2016 7 | 20 | 2 | 22 |
| 2016 6 | 17 | 6 | 23 |
| 2016 5 | 20 | 17 | 37 |
| 2016 4 | 10 | 8 | 18 |
| 2016 3 | 19 | 17 | 36 |
| 2016 2 | 10 | 6 | 16 |
| 2015 1 | 18 | 4 | 22 |
| 2015 12 | 17 | 1 | 18 |
| 2015 11 | 18 | 3 | 21 |
| 2015 10 | 20 | 4 | 24 |
| 2015 9 | 25 | 4 | 29 |
| 2015 8 | 11 | 3 | 14 |
| 2015 7 | 13 | 3 | 16 |
| 2015 6 | 20 | 6 | 26 |
| 2015 5 | 8 | 0 | 8 |
| 2015 4 | 12 | 7 | 19 |
| 2015 3 | 19 | 8 | 27 |
| 2015 2 | 14 | 6 | 20 |
| 2015 1 | 25 | 3 | 28 |
| 2014 12 | 23 | 3 | 26 |
| 2014 11 | 29 | 5 | 34 |
| 2014 10 | 36 | 4 | 40 |
| 2014 9 | 26 | 5 | 31 |
| 2014 8 | 39 | 2 | 41 |
| 2014 7 | 43 | 3 | 46 |
| 2014 6 | 25 | 2 | 27 |
| 2014 5 | 21 | 2 | 23 |
| 2014 4 | 23 | 2 | 25 |
| 2014 3 | 20 | 3 | 23 |
| 2014 2 | 23 | 0 | 23 |
| 2014 1 | 22 | 6 | 28 |
| 2013 12 | 32 | 3 | 35 |
| 2013 11 | 27 | 2 | 29 |
| 2013 10 | 41 | 5 | 46 |
| 2013 9 | 20 | 3 | 23 |
| 2013 8 | 26 | 3 | 29 |
| 2013 7 | 31 | 2 | 33 |
| 2003 11 | 797 | 0 | 797 |
Mostrar todo